Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on October 21, 2002

Circulation. 2002
Published online before print October 21, 2002, doi: 10.1161/01.CIR.0000038110.69369.4C
A more recent version of this article appeared on November 12, 2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
106/20/2608    most recent
01.CIR.0000038110.69369.4Cv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Knuefermann, P.
Right arrow Articles by Vallejo, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Knuefermann, P.
Right arrow Articles by Vallejo, J. G.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Contractile function
Right arrow Animal models of human disease

Submitted on May 21, 2002
Revised on August 14, 2002
Accepted on August 21, 2002

CD14-Deficient Mice Are Protected Against Lipopolysaccharide-Induced Cardiac Inflammation and Left Ventricular Dysfunction

Pascal Knuefermann MD, Shintaro Nemoto MD, PhD, Arunima Misra MD, Naoki Nozaki MD, Gilberto Defreitas BS, Sanna M. Goyert PhD, Blase A. Carabello MD, Douglas L. Mann MD, and Jesus G. Vallejo MD*

From the Department of Pediatrics, Section of Infectious Diseases (J.G.V.), and Department of Medicine (P.K., A.M., N.N., D.L.M., J.G.V.), Winters Center For Heart Failure Research, Veterans Affairs Medical Center (S.N., B.A.C.), Baylor College of Medicine, Houston, Tex; and North Shore University Hospital (S.M.G.), Manhasset, NY.

* To whom correspondence should be addressed. E-mail: jvallejo{at}bcm.tmc.edu.

Background—The molecular mechanisms responsible for sepsis-induced myocardial dysfunction remain undefined. CD14 mediates the inflammatory response to lipopolysaccharide (LPS) in various organs including the heart. In this study we investigated the role of CD14 in LPS-induced myocardial dysfunction in vivo.

Methods and Results—Wild-type and CD14-deficient (CD14-D) mice were challenged with Escherichia coli LPS. Myocardial tumor necrosis factor, interleukin-1ß (IL-1ß), and NOS2 induction was measured before and 6 hours after LPS challenge. Echocardiographic parameters of left ventricular function were measured before and 6 hours after LPS administration. LPS challenge induced a significant increase in myocardial tumor necrosis factor and IL-1ß mRNA and protein expression in wild-type mice. In contrast, mRNA and protein levels for TNF and IL-1ß were significantly blunted in CD14-D mice. An increase in NOS2 protein was noted within 6 hours of LPS provocation only in the hearts of wild-type mice. This was associated with an increase in ventricular cGMP levels. Activation of nuclear factor-{kappa}B was observed within 30 minutes of LPS in the hearts of wild-type mice but not in CD14-D mice. In wild-type mice, LPS significantly decreased left ventricular fractional shortening, velocity of circumferential shortening, and dP/dtmax. LPS-treated CD14-D mice maintained normal cardiac function.

Conclusions—These results suggest that CD14 is important in mediating the proinflammatory response induced by LPS in the heart and that CD14 is necessary for the development of left ventricular dysfunction during LPS-induced shock in vivo.


Key words: immune system • shock • inflammation • echocardiography




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
L. N. Jackson, L. A. Chen, S. D. Larson, S. R. Silva, P. G. Rychahou, P. J. Boor, J. Li, G. DeFreitas, W. L. Stafford, C. M. Townsend Jr., et al.
Development and Characterization of a Novel In vivo Model of Carcinoid Syndrome
Clin. Cancer Res., April 15, 2009; 15(8): 2747 - 2755.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Chao
Toll-like receptor signaling: a critical modulator of cell survival and ischemic injury in the heart
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H1 - H12.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Feng, H. Zhao, X. Xu, E. S. Buys, M. J. Raher, J. C. Bopassa, H. Thibault, M. Scherrer-Crosbie, U. Schmidt, and W. Chao
Innate immune adaptor MyD88 mediates neutrophil recruitment and myocardial injury after ischemia-reperfusion in mice
Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1311 - H1318.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. H. Boyd, B. Kan, H. Roberts, Y. Wang, and K. R. Walley
S100A8 and S100A9 Mediate Endotoxin-Induced Cardiomyocyte Dysfunction via the Receptor for Advanced Glycation End Products
Circ. Res., May 23, 2008; 102(10): 1239 - 1246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. Knuefermann, M. Schwederski, M. Velten, P. Krings, H. Ehrentraut, M. Rudiger, O. Boehm, K. Fink, U. Dreiner, C. Grohe, et al.
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of Toll-like receptor 9
Cardiovasc Res, April 1, 2008; 78(1): 26 - 35.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
S. Metkar, S. Awasthi, E. Denamur, K. S. Kim, S. C. Gangloff, S. Teichberg, A. Haziot, J. Silver, and S. M. Goyert
Role of CD14 in Responses to Clinical Isolates of Escherichia coli: Effects of K1 Capsule Expression
Infect. Immun., November 1, 2007; 75(11): 5415 - 5424.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Ehrentraut, S. Frede, H. Stapel, T. Mengden, C. Grohe, J. Fandrey, R. Meyer, and G. Baumgarten
Antagonism of Lipopolysaccharide-Induced Blood Pressure Attenuation and Vascular Contractility
Arterioscler Thromb Vasc Biol, October 1, 2007; 27(10): 2170 - 2176.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
H. Stapel, S.-C. Kim, S. Osterkamp, P. Knuefermann, A. Hoeft, R. Meyer, C. Grohe, and G. Baumgarten
Toll-like receptor 4 modulates myocardial ischaemia-reperfusion injury: Role of matrix metalloproteinases
Eur J Heart Fail, November 1, 2006; 8(7): 665 - 672.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
X. Zhu, H. Zhao, A. R. Graveline, E. S. Buys, U. Schmidt, K. D. Bloch, A. Rosenzweig, and W. Chao
MyD88 and NOS2 are essential for Toll-like receptor 4-mediated survival effect in cardiomyocytes
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1900 - H1909.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
S. Genth-Zotz, S. von Haehling, A. P. Bolger, P. R. Kalra, R. Wensel, A. J.S. Coats, H.-D. Volk, and S. D. Anker
The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure
Eur J Heart Fail, June 1, 2006; 8(4): 366 - 372.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Tao, V. T. Enoh, C. Y. Lin, W. E. Johnston, P. Li, and E. R. Sherwood
Cardiovascular dysfunction caused by cecal ligation and puncture is attenuated in CD8 knockout mice treated with anti-asialoGM1
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R478 - R485.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Chao, Y. Shen, X. Zhu, H. Zhao, M. Novikov, U. Schmidt, and A. Rosenzweig
Lipopolysaccharide Improves Cardiomyocyte Survival and Function after Serum Deprivation
J. Biol. Chem., June 10, 2005; 280(23): 21997 - 22005.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
F. Chagnon, C. N. Metz, R. Bucala, and O. Lesur
Endotoxin-Induced Myocardial Dysfunction: Effects of Macrophage Migration Inhibitory Factor Neutralization
Circ. Res., May 27, 2005; 96(10): 1095 - 1102.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
I. A. Sebag, M. D. Handschumacher, F. Ichinose, J. G. Morgan, R. Hataishi, A. C. T. Rodrigues, J. L. Guerrero, W. Steudel, M. J. Raher, E. F. Halpern, et al.
Quantitative Assessment of Regional Myocardial Function in Mice by Tissue Doppler Imaging: Comparison With Hemodynamics and Sonomicrometry
Circulation, May 24, 2005; 111(20): 2611 - 2616.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. Knuefermann, Y. Sakata, J. S. Baker, C.-H. Huang, K. Sekiguchi, H. S. Hardarson, O. Takeuchi, S. Akira, and J. G. Vallejo
Toll-Like Receptor 2 Mediates Staphylococcus aureus-Induced Myocardial Dysfunction and Cytokine Production in the Heart
Circulation, December 14, 2004; 110(24): 3693 - 3698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
W. Tao and E. R. Sherwood
{beta}2-Microglobulin knockout mice treated with anti-asialoGM1 exhibit improved hemodynamics and cardiac contractile function during acute intra-abdominal sepsis
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R569 - R575.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
M.-L. Wong, F. O'Kirwan, N. Khan, J. Hannestad, K. H. Wu, D. Elashoff, G. Lawson, P. W. Gold, S. M. McCann, and J. Licinio
Identification, characterization, and gene expression profiling of endotoxin-induced myocarditis
PNAS, November 25, 2003; 100(24): 14241 - 14246.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. de Kleijn and G. Pasterkamp
Toll-like receptors in cardiovascular diseases
Cardiovasc Res, October 15, 2003; 60(1): 58 - 67.
[Abstract] [Full Text] [PDF]